The state of Washington currently has 13 active clinical trials seeking participants for Alzheimer's Disease research studies. These trials are conducted in various cities, including Seattle, Spokane, Tacoma and Vancouver.
Apolipoprotein E (APOE) Genotype Effects on Triglycerides and Blood Flow in the Human Brain
NCT04692441
Recruiting
High fat feeding (HFF) increases the risk of Alzheimer's disease (AD) but individuals who carry the AD risk gene E4 paradoxically improve after acute HFF. The investigators propose to further study this phenomenon with a clinical study to assess cerebral blood flow which can be measured by a technique called arterial spin labeling (ASL) on an MRI and is tightly related to brain metabolism.
Gender:
All
Ages:
55 years and above
Trial Updated:
11/10/2022
Locations: University of Washington Medical Center, Seattle, Washington
Conditions: Alzheimer Disease, Dementia
Register for Updates